SEM — Select Medical Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- $3.69bn
- $7.58bn
- $6.66bn
- 81
- 68
- 75
- 87
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 201 | 345 | 500 | 198 | 300 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 52.1 | 13.4 | 23.6 | 33 | 30.2 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -13.1 | 479 | -330 | -160 | 59.5 |
Change in Accounts Receivable | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 445 | 1,028 | 401 | 285 | 582 |
Capital Expenditures | -157 | -146 | -181 | -190 | -229 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -160 | 31.1 | -76.1 | -36 | -39.3 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -317 | -115 | -257 | -226 | -268 |
Financing Cash Flow Items | -3.64 | -607 | -713 | -39.5 | -46.9 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 32.3 | -672 | -647 | -34.9 | -327 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 161 | 241 | -503 | 23.6 | -13.9 |